Global End-Stage Kidney Disease Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global End-Stage Kidney Disease Treatment Market Size 2017-2028

2.1.2 End-Stage Kidney Disease Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 End-Stage Kidney Disease Treatment Segment by Type

2.2.1 MK-3866

2.2.2 Pacritinib

2.2.3 Sanguinate

2.2.4 Tesidolumab

2.2.5 Others

2.3 End-Stage Kidney Disease Treatment Market Size by Type

2.3.1 End-Stage Kidney Disease Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global End-Stage Kidney Disease Treatment Market Size Market Share by Type (2017-2022)

2.4 End-Stage Kidney Disease Treatment Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 End-Stage Kidney Disease Treatment Market Size by Application

2.5.1 End-Stage Kidney Disease Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global End-Stage Kidney Disease Treatment Market Size Market Share by Application (2017-2022)

3 End-Stage Kidney Disease Treatment Market Size by Player

3.1 End-Stage Kidney Disease Treatment Market Size Market Share by Players

3.1.1 Global End-Stage Kidney Disease Treatment Revenue by Players (2020-2022)

3.1.2 Global End-Stage Kidney Disease Treatment Revenue Market Share by Players (2020-2022)

3.2 Global End-Stage Kidney Disease Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 End-Stage Kidney Disease Treatment by Regions

4.1 End-Stage Kidney Disease Treatment Market Size by Regions (2017-2022)

4.2 Americas End-Stage Kidney Disease Treatment Market Size Growth (2017-2022)

4.3 APAC End-Stage Kidney Disease Treatment Market Size Growth (2017-2022)

4.4 Europe End-Stage Kidney Disease Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa End-Stage Kidney Disease Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas End-Stage Kidney Disease Treatment Market Size by Country (2017-2022)

5.2 Americas End-Stage Kidney Disease Treatment Market Size by Type (2017-2022)

5.3 Americas End-Stage Kidney Disease Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC End-Stage Kidney Disease Treatment Market Size by Region (2017-2022)

6.2 APAC End-Stage Kidney Disease Treatment Market Size by Type (2017-2022)

6.3 APAC End-Stage Kidney Disease Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe End-Stage Kidney Disease Treatment by Country (2017-2022)

7.2 Europe End-Stage Kidney Disease Treatment Market Size by Type (2017-2022)

7.3 Europe End-Stage Kidney Disease Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa End-Stage Kidney Disease Treatment by Region (2017-2022)

8.2 Middle East & Africa End-Stage Kidney Disease Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa End-Stage Kidney Disease Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global End-Stage Kidney Disease Treatment Market Forecast

10.1 Global End-Stage Kidney Disease Treatment Forecast by Regions (2023-2028)

10.1.1 Global End-Stage Kidney Disease Treatment Forecast by Regions (2023-2028)

10.1.2 Americas End-Stage Kidney Disease Treatment Forecast

10.1.3 APAC End-Stage Kidney Disease Treatment Forecast

10.1.4 Europe End-Stage Kidney Disease Treatment Forecast

10.1.5 Middle East & Africa End-Stage Kidney Disease Treatment Forecast

10.2 Americas End-Stage Kidney Disease Treatment Forecast by Country (2023-2028)

10.2.1 United States End-Stage Kidney Disease Treatment Market Forecast

10.2.2 Canada End-Stage Kidney Disease Treatment Market Forecast

10.2.3 Mexico End-Stage Kidney Disease Treatment Market Forecast

10.2.4 Brazil End-Stage Kidney Disease Treatment Market Forecast

10.3 APAC End-Stage Kidney Disease Treatment Forecast by Region (2023-2028)

10.3.1 China End-Stage Kidney Disease Treatment Market Forecast

10.3.2 Japan End-Stage Kidney Disease Treatment Market Forecast

10.3.3 Korea End-Stage Kidney Disease Treatment Market Forecast

10.3.4 Southeast Asia End-Stage Kidney Disease Treatment Market Forecast

10.3.5 India End-Stage Kidney Disease Treatment Market Forecast

10.3.6 Australia End-Stage Kidney Disease Treatment Market Forecast

10.4 Europe End-Stage Kidney Disease Treatment Forecast by Country (2023-2028)

10.4.1 Germany End-Stage Kidney Disease Treatment Market Forecast

10.4.2 France End-Stage Kidney Disease Treatment Market Forecast

10.4.3 UK End-Stage Kidney Disease Treatment Market Forecast

10.4.4 Italy End-Stage Kidney Disease Treatment Market Forecast

10.4.5 Russia End-Stage Kidney Disease Treatment Market Forecast

10.5 Middle East & Africa End-Stage Kidney Disease Treatment Forecast by Region (2023-2028)

10.5.1 Egypt End-Stage Kidney Disease Treatment Market Forecast

10.5.2 South Africa End-Stage Kidney Disease Treatment Market Forecast

10.5.3 Israel End-Stage Kidney Disease Treatment Market Forecast

10.5.4 Turkey End-Stage Kidney Disease Treatment Market Forecast

10.5.5 GCC Countries End-Stage Kidney Disease Treatment Market Forecast

10.6 Global End-Stage Kidney Disease Treatment Forecast by Type (2023-2028)

10.7 Global End-Stage Kidney Disease Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 BLR Bio LLC

11.1.1 BLR Bio LLC Company Information

11.1.2 BLR Bio LLC End-Stage Kidney Disease Treatment Product Offered

11.1.3 BLR Bio LLC End-Stage Kidney Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 BLR Bio LLC Main Business Overview

11.1.5 BLR Bio LLC Latest Developments

11.2 CTI BioPharma Corp

11.2.1 CTI BioPharma Corp Company Information

11.2.2 CTI BioPharma Corp End-Stage Kidney Disease Treatment Product Offered

11.2.3 CTI BioPharma Corp End-Stage Kidney Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 CTI BioPharma Corp Main Business Overview

11.2.5 CTI BioPharma Corp Latest Developments

11.3 F. Hoffmann-La Roche Ltd

11.3.1 F. Hoffmann-La Roche Ltd Company Information

11.3.2 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Product Offered

11.3.3 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 F. Hoffmann-La Roche Ltd Main Business Overview

11.3.5 F. Hoffmann-La Roche Ltd Latest Developments

11.4 Novartis AG

11.4.1 Novartis AG Company Information

11.4.2 Novartis AG End-Stage Kidney Disease Treatment Product Offered

11.4.3 Novartis AG End-Stage Kidney Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis AG Main Business Overview

11.4.5 Novartis AG Latest Developments

11.5 Prolong Pharmaceuticals LLC

11.5.1 Prolong Pharmaceuticals LLC Company Information

11.5.2 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Product Offered

11.5.3 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Prolong Pharmaceuticals LLC Main Business Overview

11.5.5 Prolong Pharmaceuticals LLC Latest Developments

11.6 VESSL Therapeutics Ltd

11.6.1 VESSL Therapeutics Ltd Company Information

11.6.2 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Product Offered

11.6.3 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 VESSL Therapeutics Ltd Main Business Overview

11.6.5 VESSL Therapeutics Ltd Latest Developments

12 Research Findings and Conclusion

Table 1. End-Stage Kidney Disease Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of MK-3866

Table 3. Major Players of Pacritinib

Table 4. Major Players of Sanguinate

Table 5. Major Players of Tesidolumab

Table 6. Major Players of Others

Table 7. End-Stage Kidney Disease Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global End-Stage Kidney Disease Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global End-Stage Kidney Disease Treatment Market Size Market Share by Type (2017-2022)

Table 10. End-Stage Kidney Disease Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global End-Stage Kidney Disease Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global End-Stage Kidney Disease Treatment Market Size Market Share by Application (2017-2022)

Table 13. Global End-Stage Kidney Disease Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global End-Stage Kidney Disease Treatment Revenue Market Share by Player (2020-2022)

Table 15. End-Stage Kidney Disease Treatment Key Players Head office and Products Offered

Table 16. End-Stage Kidney Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global End-Stage Kidney Disease Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global End-Stage Kidney Disease Treatment Market Size Market Share by Regions (2017-2022)

Table 21. Americas End-Stage Kidney Disease Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas End-Stage Kidney Disease Treatment Market Size Market Share by Country (2017-2022)

Table 23. Americas End-Stage Kidney Disease Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas End-Stage Kidney Disease Treatment Market Size Market Share by Type (2017-2022)

Table 25. Americas End-Stage Kidney Disease Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas End-Stage Kidney Disease Treatment Market Size Market Share by Application (2017-2022)

Table 27. APAC End-Stage Kidney Disease Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC End-Stage Kidney Disease Treatment Market Size Market Share by Region (2017-2022)

Table 29. APAC End-Stage Kidney Disease Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC End-Stage Kidney Disease Treatment Market Size Market Share by Type (2017-2022)

Table 31. APAC End-Stage Kidney Disease Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC End-Stage Kidney Disease Treatment Market Size Market Share by Application (2017-2022)

Table 33. Europe End-Stage Kidney Disease Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe End-Stage Kidney Disease Treatment Market Size Market Share by Country (2017-2022)

Table 35. Europe End-Stage Kidney Disease Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe End-Stage Kidney Disease Treatment Market Size Market Share by Type (2017-2022)

Table 37. Europe End-Stage Kidney Disease Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe End-Stage Kidney Disease Treatment Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa End-Stage Kidney Disease Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa End-Stage Kidney Disease Treatment Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa End-Stage Kidney Disease Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa End-Stage Kidney Disease Treatment Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa End-Stage Kidney Disease Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa End-Stage Kidney Disease Treatment Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of End-Stage Kidney Disease Treatment

Table 46. Key Market Challenges & Risks of End-Stage Kidney Disease Treatment

Table 47. Key Industry Trends of End-Stage Kidney Disease Treatment

Table 48. Global End-Stage Kidney Disease Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global End-Stage Kidney Disease Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global End-Stage Kidney Disease Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global End-Stage Kidney Disease Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global End-Stage Kidney Disease Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global End-Stage Kidney Disease Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 54. BLR Bio LLC Details, Company Type, End-Stage Kidney Disease Treatment Area Served and Its Competitors

Table 55. BLR Bio LLC End-Stage Kidney Disease Treatment Product Offered

Table 56. BLR Bio LLC End-Stage Kidney Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. BLR Bio LLC Main Business

Table 58. BLR Bio LLC Latest Developments

Table 59. CTI BioPharma Corp Details, Company Type, End-Stage Kidney Disease Treatment Area Served and Its Competitors

Table 60. CTI BioPharma Corp End-Stage Kidney Disease Treatment Product Offered

Table 61. CTI BioPharma Corp Main Business

Table 62. CTI BioPharma Corp End-Stage Kidney Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. CTI BioPharma Corp Latest Developments

Table 64. F. Hoffmann-La Roche Ltd Details, Company Type, End-Stage Kidney Disease Treatment Area Served and Its Competitors

Table 65. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Product Offered

Table 66. F. Hoffmann-La Roche Ltd Main Business

Table 67. F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. F. Hoffmann-La Roche Ltd Latest Developments

Table 69. Novartis AG Details, Company Type, End-Stage Kidney Disease Treatment Area Served and Its Competitors

Table 70. Novartis AG End-Stage Kidney Disease Treatment Product Offered

Table 71. Novartis AG Main Business

Table 72. Novartis AG End-Stage Kidney Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Novartis AG Latest Developments

Table 74. Prolong Pharmaceuticals LLC Details, Company Type, End-Stage Kidney Disease Treatment Area Served and Its Competitors

Table 75. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Product Offered

Table 76. Prolong Pharmaceuticals LLC Main Business

Table 77. Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Prolong Pharmaceuticals LLC Latest Developments

Table 79. VESSL Therapeutics Ltd Details, Company Type, End-Stage Kidney Disease Treatment Area Served and Its Competitors

Table 80. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Product Offered

Table 81. VESSL Therapeutics Ltd Main Business

Table 82. VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. VESSL Therapeutics Ltd Latest Developments

List of Figures

Figure 1. End-Stage Kidney Disease Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global End-Stage Kidney Disease Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global End-Stage Kidney Disease Treatment Market Size Market Share by Type in 2021

Figure 7. End-Stage Kidney Disease Treatment in Clinic

Figure 8. Global End-Stage Kidney Disease Treatment Market: Clinic (2017-2022) & ($ Millions)

Figure 9. End-Stage Kidney Disease Treatment in Hospital

Figure 10. Global End-Stage Kidney Disease Treatment Market: Hospital (2017-2022) & ($ Millions)

Figure 11. End-Stage Kidney Disease Treatment in Others

Figure 12. Global End-Stage Kidney Disease Treatment Market: Others (2017-2022) & ($ Millions)

Figure 13. Global End-Stage Kidney Disease Treatment Market Size Market Share by Application in 2021

Figure 14. Global End-Stage Kidney Disease Treatment Revenue Market Share by Player in 2021

Figure 15. Global End-Stage Kidney Disease Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas End-Stage Kidney Disease Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC End-Stage Kidney Disease Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe End-Stage Kidney Disease Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa End-Stage Kidney Disease Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas End-Stage Kidney Disease Treatment Value Market Share by Country in 2021

Figure 21. Americas End-Stage Kidney Disease Treatment Consumption Market Share by Type in 2021

Figure 22. Americas End-Stage Kidney Disease Treatment Market Size Market Share by Application in 2021

Figure 23. United States End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC End-Stage Kidney Disease Treatment Market Size Market Share by Region in 2021

Figure 28. APAC End-Stage Kidney Disease Treatment Market Size Market Share by Application in 2021

Figure 29. China End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe End-Stage Kidney Disease Treatment Market Size Market Share by Country in 2021

Figure 36. Europe End-Stage Kidney Disease Treatment Market Size Market Share by Type in 2021

Figure 37. Europe End-Stage Kidney Disease Treatment Market Size Market Share by Application in 2021

Figure 38. Germany End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa End-Stage Kidney Disease Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa End-Stage Kidney Disease Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa End-Stage Kidney Disease Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country End-Stage Kidney Disease Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries End-Stage Kidney Disease Treatment Market Size 2023-2028 ($ Millions)